Marina Simian

Dr. Marina Simian

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2016 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MSMarina Simian
Marina Simian
MBMina J. Bissell
Mina J. Bissell
In the last ten years, there has been a dramatic surge in the number of publications where single or groups of cells are grown in substrata that have elements of basement membrane leading to the formation of tissue-like structures referred to as organoids. However, this field of research began many decades ago, when the pioneers of cell culture began to ask questions we still ask today: How does organogenesis occur? How do signals integrate to make such vastly different tissues and organs given that the sequence of the genome in our trillions of cells is identical? Here, we summarize how work over the past century generated the conceptual framework that has allowed us to make progress in the understanding of tissue-specific morphogenetic programs. The development of cell culture systems that provide accurate and physiologically relevant models are proving to be key in establishing appropriate platforms for the development of new therapeutic strategies.

21 September 2011 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
OPOsvaldo Pontiggia
Osvaldo Pontiggia
RSRocio Sampayo
Rocio Sampayo
DRDiego Raffo
Diego Raffo
AMAndrea Motter
Andrea Motter
RXRen Xu
Ren Xu
MSMarina Simian
Marina Simian

14 May 2001 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
YHYohei Hirai
Yohei Hirai
DRDerek Radisky
Derek Radisky
RBRosanne Boudreau
Rosanne Boudreau
MSMarina Simian
Marina Simian
MSMary E. Stevens
Mary E. Stevens
MBMina J. Bissell
Mina J. Bissell
We have shown previously that epimorphin (EPM), a protein expressed on the surface of myoepithelial and fibroblast cells of the mammary gland, acts as a multifunctional morphogen of mammary epithelial cells. Here, we present the molecular mechanism by which EPM mediates luminal morphogenesis. Treatment of cells with EPM to induce lumen formation greatly increases the overall expression of transcription factor CCAAT/enhancer binding protein (C/EBP)β and alters the relative expression of its two principal isoforms, LIP and LAP. These alterations were shown to be essential for the morphogenetic activities, since constitutive expression of LIP was sufficient to produce lumen formation, whereas constitutive expression of LAP blocked EPM-mediated luminal morphogenesis. Furthermore, in a transgenic mouse model in which EPM expression was expressed in an apolar fashion on the surface of mammary epithelial cells, we found increased expression of C/EBPβ, increased relative expression of LIP to LAP, and enlarged ductal lumina. Together, our studies demonstrate a role for EPM in luminal morphogenesis through control of C/EBPβ expression.

6 July 2018 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
RSRocío G. Sampayo
Rocío G. Sampayo
ATAndrés M. Toscani
Andrés M. Toscani
MRMatthew G. Rubashkin
Matthew G. Rubashkin
KTKate Thi
Kate Thi
LMLuciano A. Masullo
Luciano A. Masullo
MSMarina Simian
Marina Simian
Estrogen receptor α (ERα) is expressed in tissues as diverse as brains and mammary glands. In breast cancer, ERα is a key regulator of tumor progression. Therefore, understanding what activates ERα is critical for cancer treatment in particular and cell biology in general. Using biochemical approaches and superresolution microscopy, we show that estrogen drives membrane ERα into endosomes in breast cancer cells and that its fate is determined by the presence of fibronectin (FN) in the extracellular matrix; it is trafficked to lysosomes in the absence of FN and avoids the lysosomal compartment in its presence. In this context, FN prolongs ERα half-life and strengthens its transcriptional activity. We show that ERα is associated with β1-integrin at the membrane, and this integrin follows the same endocytosis and subcellular trafficking pathway triggered by estrogen. Moreover, ERα+ vesicles are present within human breast tissues, and colocalization with β1-integrin is detected primarily in tumors. Our work unravels a key, clinically relevant mechanism of microenvironmental regulation of ERα signaling.

8 August 2019 in Frontiers in Endocrinology
Verified
Journal Article
Open access
MBMaría Inés Diaz Bessone
María Inés Diaz Bessone
MGMaría José Gattas
María José Gattas
TLTomás Laporte
Tomás Laporte
MTMax Tanaka
Max Tanaka
MSMarina Simian
Marina Simian
Estrogen receptor positive breast neoplasias represent over 70% of diagnosed breast cancers. Depending on the stage at which the tumor is detected, HER2 status and genomic risk, endocrine therapy is combined with either radio, chemo and/or targeted therapy. A growing amount of evidence supports the notion that components of the tumor microenvironment play specific roles in response to treatment and that strategies targeting these key interactions with tumor cells could pave the way to a new generation of therapies. In this review, we analyze the evidence suggesting different components of the tumor microenvironment play a role in hormone receptor positive breast cancer progression. In particular we focus on the immune system, carcinoma associated fibroblasts and the extracellular matrix. Further insight into the cross talk between these constituents of the microenvironment and the tumor cells may lead to therapies that eliminate disseminated metastatic cells early on, and thus reduce distant disease relapse which is the leading cause of death for patients who are diagnosed with this illness.

1 June 2016 in Cancer Letters
Verified
Journal Article
Closed access
EBEileen Brantley
Eileen Brantley
MCMariana A. Callero
Mariana A. Callero
DBDamian E. Berardi
Damian E. Berardi
PCPetreena Campbell
Petreena Campbell
LRLeah Rowland
Leah Rowland
USUbaldo Soto
Ubaldo Soto